Thermo Fisher Scientific (TMO) Increases Availability of COVID-19 Testing with Sample Collection Kit from Everlywell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- Citi highlights best Gen AI stocks to own for 2027
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- Netflix raises prices in Germany and Austria, Citi comments
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Thermo Fisher Scientific (TMO) Tops Q3 EPS by $1.32, Revenues Beat
October 21, 2020 6:02 AM EDTThermo Fisher Scientific (NYSE: TMO) reported Q3 EPS of $5.63, $1.32 better than the analyst estimate of $4.31. Revenue for the quarter came in at $8.52 billion versus the consensus estimate of $7.65 billion.
Third Quarter 2020 Highlights
Third quarter revenue increased 36% to $8.52 billion.Third quarter GAAP diluted earnings per share (EPS) increased 157% to $4.84.Third quarter adjusted EPS increased 91% to $5.63.Generated $2.0 billion of COVID-19 related revenue in the quarter and returned the base business to growth.Further expanded our global pandemic response, including launching the Amplitude Solution to automate high-throughput PCR-based testing, adding... More